Paxman, the global leader in cancer side effect management, today announced that the American Medical Association (AMA) CPT Editorial Panel has established three Category III CPT® codes describing the ...

Podiatrist-Approved and Recommended by Medical Experts: Unlike gimmicky devices that promise results without evidence, ...

Tactile Systems Technology, Inc. (NASDAQ:TCMD) Q4 2025 Earnings Call Transcript February 18, 2026 Operator: Welcome, ladies and gentlemen, to the Fourth Quarter and Full Year 2025 Earnings Conference ...

As the pharma patent cliff approaches, delve into which important drugs are about to lose exclusivity and how the industry is reacting.

Canton-area communities, create 100 local jobs, and expand Onelife Fitness's Atlanta footprint MCLEAN, VIRGINIA / ACCESS Newswire / February 23, 2026 ...

Aurinia Pharmaceuticals reports fourth-quarter earnings Thursday before the market opens, as investors look for signs the biotech can sustain robust revenue growth for its lupus nephritis therapy ...

Q4 2025 Earnings Call February 24, 2026 5:00 PM ESTCompany ParticipantsLorna Williams - Senior Vice President of Investor ...

I asked Dr. Eli Rogers to share his insight on the most effective pain-relieving methods and top tips to recover from injury.

Hinge Health (HNGE) analysis: 2025 growth, strong FCF margins, and a durable AI-resistant moat. Click here to read my most recent analysis of HNGE stock.

The global scar treatment market is growing robustly, expected to be valued at around US$ 23.0 billion in 2026 and projected to reach US$ ...

Biotech dealmaking is increasingly defined by a clear strategic shift: Pharmaceutical companies are prioritizing de-risked, ...

Detailed price information for Takeda Pharmaceutical Ltd ADR (TAK-N) from The Globe and Mail including charting and trades.